HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolomic profiling identifies complex lipid species and amino acid analogues associated with response to weight loss interventions.

Abstract
Obesity is an epidemic internationally. While weight loss interventions are efficacious, they are compounded by heterogeneity with regards to clinically relevant metabolic responses. Thus, we sought to identify metabolic biomarkers that are associated with beneficial metabolic changes to weight loss and which distinguish individuals with obesity who would most benefit from a given type of intervention. Liquid chromatography mass spectrometry-based profiling was used to measure 765 metabolites in baseline plasma from three different weight loss studies: WLM (behavioral intervention, N = 443), STRRIDE-PD (exercise intervention, N = 163), and CBD (surgical cohort, N = 125). The primary outcome was percent change in insulin resistance (as measured by the Homeostatic Model Assessment of Insulin Resistance [%ΔHOMA-IR]) over the intervention. Overall, 92 individual metabolites were associated with %ΔHOMA-IR after adjustment for multiple comparisons. Concordantly, the most significant metabolites were triacylglycerols (TAGs; p = 2.3e-5) and diacylglycerols (DAGs; p = 1.6e-4), with higher baseline TAG and DAG levels associated with a greater improvement in insulin resistance with weight loss. In tests of heterogeneity, 50 metabolites changed differently between weight loss interventions; we found amino acids, peptides, and their analogues to be most significant (4.7e-3) in this category. Our results highlight novel metabolic pathways associated with heterogeneity in response to weight loss interventions, and related biomarkers which could be used in future studies of personalized approaches to weight loss interventions.
AuthorsNathan A Bihlmeyer, Lydia Coulter Kwee, Clary B Clish, Amy Anderson Deik, Robert E Gerszten, Neha J Pagidipati, Blandine Laferrère, Laura P Svetkey, Christopher B Newgard, William E Kraus, Svati H Shah
JournalPloS one (PLoS One) Vol. 16 Issue 5 Pg. e0240764 ( 2021) ISSN: 1932-6203 [Electronic] United States
PMID34043632 (Publication Type: Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Diglycerides
  • Lipids
  • Triglycerides
Topics
  • Adult
  • Biomarkers (blood)
  • Body Mass Index
  • Diglycerides (blood)
  • Female
  • Humans
  • Insulin Resistance (physiology)
  • Lipid Metabolism (physiology)
  • Lipids (blood)
  • Male
  • Mass Spectrometry
  • Metabolomics
  • Middle Aged
  • Obesity (blood, metabolism, surgery, therapy)
  • Triglycerides (blood)
  • Weight Loss (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: